{"name":"Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.","slug":"asia-stem-cell-regenerative-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. is a biotechnology company focused on developing regenerative therapies, particularly in the field of stem cell research. The company's lead product, UC-MSC infusion, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQQjhJTTVWOUdSWlQxdHNtemltRFQ1eVdkS0NKbzJyUzlMSXhOMlJXa0YyVlhjZnBwT2FlVGFhQXJVWTFCeGpncDAxUFUwbkcydDlMWlFLeHFTQjV3Y09hdVBoTF9BQm5pcHBGbDF5d1pycHc2TWw5TVRWSUpPNUtLTTU5Rlk5Vmo3cFFkUzB3RFo2RUxCTGY0Ni1WZW4yaDNyUjNv?oc=5","date":"2026-03-16","type":"pipeline","source":"Fortune Business Insights","summary":"Induced Pluripotent Stem Cells Market Size, Share | Forecast, 2034 - Fortune Business Insights","headline":"Induced Pluripotent Stem Cells Market Size, Share | Forecast, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPdU10a3JqWDBiNjlzOW9MemJPNko1NzZaMEplVkxfZXRVS2plaTljNGJ5RUlybmpJaTRFMVVVVGxsRmRiTDVURGpZczZrVnBaV25BV2ZPbnJ0akNVa2V4MVJSSGx4a1RmcDV4TzN5VkhOR3ppMWpXckpUWEpOejRscWdyNDJOOHdCRG93aTZDeU8?oc=5","date":"2026-03-11","type":"trial","source":"Market Data Forecast","summary":"Induced Pluripotent Stem Cells Market Size Report, 2034 - Market Data Forecast","headline":"Induced Pluripotent Stem Cells Market Size Report, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPUml3LW9yRGZBZVM0Tmk4QjNOX0NTQmdOT1pOckRHWDUtdkNpQkRocE1WdXlrcUpiT0p3OTBQQ0dzcUFKZGZHU3JESWV4V1pPcW9CalNBWmpzUzJJcU5Wb3gwdlpEN2dmci1BNGQ0aUVXZkprSVlGMVFsZ2RublpWbHlUTW1MdHgxbE9ENURCT1JZVDdZR2U5Ql9QenJIZw?oc=5","date":"2026-03-10","type":"regulatory","source":"BioWorld News","summary":"Japan approves first iPSC therapy for Parkinson’s disease - BioWorld News","headline":"Japan approves first iPSC therapy for Parkinson’s disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQSE55bE96UXhMMDhDNkNUcnNZLWJGb1Z3SGo3d0hBR2o1NWlwZG15b01YRllyQ05ISVVBRlU1akR5VmNjY2dLaUdyLTc4RUlTWEpLWjZIMG9TenZfT2tLRHFmX2YxYVdtOUdOOHJ0cWxvNW9CV1ltTGJCOTk5YktTRDV0UEhBOHFSWG5HRUFPQTR0RGN2d0o0N2JYdWQ2bDROWTdQSTU3ZE1GRjJRM2IzaU1TRDdFMmYxd1E?oc=5","date":"2026-03-06","type":"regulatory","source":"Anadolu Ajansı","summary":"Japan approves 1st iPS stem cell therapies for heart failure, Parkinson’s - Anadolu Ajansı","headline":"Japan approves 1st iPS stem cell therapies for heart failure, Parkinson’s - Anadolu Ajansı","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE10RzhyX2tKYWllYVBBMzBnam5LRkhyX3hZLXVPZ01GLTJSTE1oeGhIcGJNcmV2MzQ0N3AxVTVEeVpfNjBxU3hMME1PWmZvLWxNekRvS0xn?oc=5","date":"2026-03-06","type":"regulatory","source":"asahi.com","summary":"Japan approves world‑first iPS cell drugs for summer release - asahi.com","headline":"Japan approves world‑first iPS cell drugs for summer release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQRnYxQktheS1pVlNUYm1PeXJhcW55cTlsQ2dlNl9Uc1hRT3pfMjlBOGtSTzFXM241TURTSUdoMXRJSnZYOWFTOVlsaGhKUXdURFh2eGVXb3hYSjNvS3pORi1nQWkwOWt3LWVTM2xCRFlseVFNVzVLU0VISFRzb0dKSG1qUTFWVW4yTk9QREg4QzJEVEQ0RTBON2xaYmNWLUFWaUpV?oc=5","date":"2026-02-24","type":"regulatory","source":"BioWorld News","summary":"Japan endorses two iPSC drugs for approval under CEA pathway - BioWorld News","headline":"Japan endorses two iPSC drugs for approval under CEA pathway","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMnFudUdSamtOOHJ6TGxjVG5oREN0WG5PcFdKSEp0QnZQcTBhQmhxX01YM1VpaHRzenctTWtYOVRFZ3d0TFNmZms5Z1BoUGFzUXFEMWRSSDVZQ000REY4b2duakdpRTBqNVVaX2RaMTBidzNQQmZxOWJrd0ZNUnVhd25vZkdMdFJMT0lrSVV4SWtzaGVZS3NiTFNkZ0s1ekp4MHRSMU1EZ2VaUXY1?oc=5","date":"2026-02-20","type":"regulatory","source":"Nikkei Asia","summary":"Japan panel approves world's first iPS cell-based therapies - Nikkei Asia","headline":"Japan panel approves world's first iPS cell-based therapies","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-02-19","type":"regulatory","source":"South China Morning Post","summary":"Japan approves world’s first regenerative medicines using iPS cells - South China Morning Post","headline":"Japan approves world’s first regenerative medicines using iPS cells","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYml3ZGJMUjR3a0xLMlhRMXpXdGRhbEpUY1lWTUFJQWl2WFoxa2RqQ2x2dWxYNTZ5SmRQSkZsdFdXbXFVYXVacUlTVFBlLU5OLU84OElpTDQ2SXM5dDJRc1VSamlfTnQ4Y01uUjloS09RMm5IU0Z2NmIxdGJ1dUhzajJDei1tYThxOW13Z0ItejlITUR5Wk5IRXJVM1gwMDlQV0FHbFJBOTk?oc=5","date":"2026-02-19","type":"regulatory","source":"The Straits Times","summary":"Japan panel approves stem cell medical products to treat heart disease and Parkinson’s - The Straits Times","headline":"Japan panel approves stem cell medical products to treat heart disease and Parkinson’s","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOV0lhVGdqM0tTQmhudkZRX2NKRVdPLUdEMzRIcE81Z1VxSmxZU1ZZVE1GSTNXcU1CT0NWLWVNX25KZjhGbHRhZnZ4LVFOUkxfcTJ4bGJacXRxdFlzcFB1UGpOZnNOZDJsTEhLUGNHY2JUcEFLekxZS2VOTW1KdWRLX1M0YlpzRFhPaE16Y3hSZ1NjczVPSER2WElpNzg?oc=5","date":"2026-01-31","type":"pipeline","source":"BioSpectrum Asia","summary":"Japan strengthening biopharma capabilities - BioSpectrum Asia","headline":"Japan strengthening biopharma capabilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBtR0M1Z1JocVZSbVFwN1FJWFM2UmFNNnZyUzhpNTBrSG82SFlFN2paVXozXzBqRGpOX2NPOVQwQS12YllnYTNKT1ZCcktWTzZNdGUxcnR5d1hmSkRMaE5ET09ReDBHd1RMN2djNE1n0gFyQVVfeXFMTjMxN29lUjBJZUtZMTdURGZuTnJ2Sk5RTTFacXV3RUsycHhhMTlLTS1aZVZheGsyUGs4LXd1MjN3ZU93MFFHMWx5UWVaTlhicVNwV3JhZE1iZkhfdVRVdm1tXy1KQnBnSVREX2c4LVRtNTZB?oc=5","date":"2025-11-03","type":"pipeline","source":"koreabiomed.com","summary":"Alfresa launches Korean subsidiary Jenecell to spearhead global stem cell expansion - koreabiomed.com","headline":"Alfresa launches Korean subsidiary Jenecell to spearhead global stem cell expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNYUxUODZSMUNzWjg2a2hJbUE4M0pIOVVtcjZyNWFBTVU1ZWVvUkNLMEk2eG1PQm5xdG1mLTczMmxkNU5QNlM0TE9fX21NM2pIVnBCel9SUmp0NDhOQUpuVndtVDhUbXVJcm13aTl5Z0tPY3hldElIZFphS3BTcGVvMmFYSlVrM19NWExtWXc0cEVEZzNMNTJ4T3hGWU5ETFhlYWxDRTlvVllJS3Q0Sm41YjFLZWFXT2NzaVUyd1dkaF9JcERtZVBiMnRULWZnYldxZEN3YVhhWDJIU3BtcjJJUUljNkp1S0pDbGFrWWZMMjE4dUtvcjIwZjlBRDZPN3dYQnN4VUxjU2lsQjd6ZGlNSEU5aXFST0pLZTJBSmplOUliTnhIQnc4?oc=5","date":"2025-09-17","type":"pipeline","source":"GlobeNewswire","summary":"Regenerative Medicine Market Size Worth USD 1,69,586 Mn by - GlobeNewswire","headline":"Regenerative Medicine Market Size Worth USD 1,69,586 Mn by","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}